Doctors track approved swelling drug in everyday use

NCT ID NCT07445087

Not yet recruiting Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study monitors how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) during routine medical care in South Korea. HAE causes sudden, severe swelling under the skin or inside the body. Researchers will track side effects and how well the drug controls swelling attacks in about 35 participants as their doctors normally treat them.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.